17.4 C
New York
Monday, June 8, 2026

Tag: marketplaces

newssourceFORcompanyinformationcontent1marketreleases

Used Jet and Piston-Single Aircraft Inventory Maintains Steady Trend While Turboprop Inventory Dips Lower

LINCOLN, Neb., July 7, 2025 /PRNewswire/ -- The Sandhills Global aviation market reports for June show mixed trends among used jets, piston-single aircraft, and turboprop...

Lightchain AI Concludes 15 Presale Phases and Launches Bonus Round With Developer Grant Program

SHREWSBURY, United Kingdom, July 07, 2025 (GLOBE NEWSWIRE) -- Lightchain AI, a blockchain infrastructure project focused on AI-native applications, has completed all 15 presale phases without delays and is now entering its Bonus Round. The project has raised $21 million to date, with tokens continuing to be available at a fixed price of $0.007.

Decision Notice – CIRO Sanctions Hongjia Liu

VANCOUVER, BC, July 4, 2025 /CNW/ - On June 18, 2025, a hearing panel of the Canadian Investment Regulatory Organization (CIRO) held a hearing...

Canadian Investment Regulatory Organization Trade Resumption – AETH

VANCOUVER, BC, July 4, 2025 /CNW/ - Trading resumes in: Company: Aether Global Innovations Corp. CSE Symbol: AETH All Issues: Yes Resumption (ET): 3:15 PM CIRO can make a...

Canadian Investment Regulatory Organization Trading Halt – JJJJ.P

VANCOUVER, BC, July 4, 2025 /CNW/ - The following issues have been halted by CIRO Company: J4 Ventures Inc. TSX-Venture Symbol: JJJJ.P All Issues: Yes Reason: Pending...

Investor Alert: Fraudulent Website Impersonating Funds Direct Canada Inc. and Falsely Claiming CIRO Registration

Be an informed investor - Protect yourself against fraudulent schemes TORONTO, July 4, 2025 /CNW/ - The Canadian Investment Regulatory Organization (CIRO) is warning investors...

Canadian Investment Regulatory Organization Trade Resumption – VRY

VANCOUVER, BC, July 4, 2025 /CNW/ - Trading resumes in: Company: Petro-Victory Energy Corp. TSX-Venture Symbol: VRY All Issues: Yes Resumption (ET): 12:30 PM CIRO can make a...

Canadian Investment Regulatory Organization Trade Resumption – LQWD

VANCOUVER, BC, July 4, 2025 /CNW/ - Trading resumes in: Company: LQWD Technologies Corp. TSX-Venture Symbol: LQWD All Issues: No Resumption (ET): 10:11:50 AM CIRO can make a decision...

Canadian Investment Regulatory Organization Trading Halt – LQWD

VANCOUVER, BC, July 4, 2025 /CNW/ - The following issues have been halted by CIRO Company: LQWD Technologies Corp. TSX-Venture Symbol: LQWD All Issues: No Reason: Single Stock...

Canadian Investment Regulatory Organization Trading Halt – HR.UN

TORONTO, July 4, 2025 /CNW/ - The following issues have been halted by CIRO: Company: H&R Real Estate Investment Trust TSX Symbol: HR.UN All Issues: Yes Reason: Pending...

Bybit TradFi x Crypto Report: Regulatory Tailwinds Drive Coinbase Outperformance Despite Premium Valuation

DUBAI, UAE, July 4, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has released a new Bybit TradFi x Crypto...

Online Loans for Bad Credit: US Loan Options for 2025

Honest Loans offers access to flexible online loan connections in 2025, supporting fast funding options for borrowers with less-than-perfect credit. 
Honest Loans offers access to flexible online loan connections in 2025, supporting fast funding options for borrowers with less-than-perfect credit.

Remote Pharmacy Releases 2025 Availability Update on GLP-1 Weight Loss Solutions and Consumer Interest in Semaglutide & Tirzepatide

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management. 
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

Decision Notice – CIRO Hearing Panel issues its Reasons for Decision in the matter of Scott Nicolas Zurevinski

CALGARY, AB, July 3, 2025 /CNW/ - Following a settlement hearing held on May 15, 2025 pursuant to the Mutual Fund Dealer Rules, on...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsMarketplaces

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers